Principales conclusions et analyse des parts de marché des thérapies CAR-T d'ici 2025-2031
CAR-T Therapy Market Report Analysis
CAR-T Therapy Market
-
CAGR (2025 - 2031)16.2% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Novartis International AG
- Kite Pharma, Inc. (Gilead Sciences, Inc.)
- Juno Therapeutics (Celgene Corporation)
- Bluebird Bio, Inc. (Celgene Corporation)
- Sorrento Therapeutics Inc.
- Mustang Bio, Inc
- Aurora Biopharma Inc.
- Legend Biotech (Genscript Biotech Corporation)
- Pfizer, Inc.
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Antigène ciblé
- CD 19
- BCMA
- HER2
- GD2
- CD 20
- CD22
- CD30
- CD33
- HER1 et autres
By Application thérapeutique
- leucémie lymphoïde aiguë
- leucémie lymphoïde chronique
- lymphome diffus à grandes cellules B
- lymphome folliculaire
- myélome multiple
- glioblastome
- sarcome
- neuroblastome
- leucémie myéloïde aiguë
- cancer du sein
- cancer du pancréas
- carcinome hépatocellulaire
- cancer colorectal et autres
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Get Free Sample For